Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 4,845.00
-105.00 (-2.12%)
At close: Apr 2, 2026
7.67% (1Y)
| Market Cap | 54.84B -7.3% |
| Revenue | 22.18B |
| Net Income | 2.97B |
| EPS | 261.00 |
| Shares Out | 11.32M |
| PE Ratio | 18.56 |
| Forward PE | n/a |
| Dividend | 185.00 (3.82%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 14,697 |
| Average Volume | 14,623 |
| Open | 4,950.00 |
| Previous Close | 4,950.00 |
| Day's Range | 4,800.00 - 5,250.00 |
| 52-Week Range | 4,355.00 - 7,690.00 |
| Beta | n/a |
| RSI | 40.30 |
| Earnings Date | Nov 27, 2025 |